Micro C Imaging Brings Hand-Held Fluoroscopy Innovation to Medical Industry Leaders

The Micro C hand-held fluoroscopy solution revolutionizes surgeries of the extremities

The lightweight Micro C emitter is agile, safe and fast

Micro C™ exhibits its hand-held X-ray solution at the American Society of Surgery for the Hand (ASSH) and the Orthopaedic Trauma Association (OTA)

This opportunity to get feedback from my fellow surgeons, for whom I invented the Micro C, will be a key milestone in our march toward successful commercial launch in 2018.”

— Gregory Kolovich MD/MPH – Co-Founder & Chief Medical Officer

ATLANTA, GEORGIA, UNITED STATES, August 31, 2017 /EINPresswire.com/ — This fall the Micro C™ team brings its revolutionary hand-held fluoroscopy to a global medical industry that applauds innovation. The Micro C enables surgeons treating disorders of the extremities to conduct surgeries with greater accuracy, clarity, safety, and speed. The solution incorporates a lightweight, ergonomically designed hand-held emitter with an X-ray and still, video and infrared camera together with an image receptor and software enabling HIPPA-compliant image and data capture and electronic medical records (EMR) system integration. Its clinical version brings breakthrough mobile X-ray capability into physicians’ offices, urgent care facilities, emergency rooms, rural medicine, and sports and military field settings.

For its initial road trip, the Micro C team heads to the 72nd Annual Meeting of the American Society for Surgery of the Hand (ASSH), exhibiting at Booth #214 at the Moscone Center in San Francisco September 7-9. Gregory Kolovich MD MPH, the company’s Co-Founder and Chief Medical Officer, presents the Micro C to his peers at the New Product Showcase on the Pavilion stage at 11:30 AM on Thursday September 7th.

For his Micro C presentation at the American Society for Surgery of the Hand, Dr. Gregory Kolovich observes, “This opportunity to get feedback from my fellow surgeons, for whom I invented the Micro C, will be a key milestone in our march toward successful commercial launch in 2018.” He and Evan Ruff, Co-Founder and CEO, have filed seven patents defining the technologies unique to the Micro C.

Next traveling to the 32nd Annual Meeting of the Orthopaedic Trauma Association to exhibit at Booth #513 at the Vancouver Convention Centre in Vancouver, BC, Canada October 12-14, the Micro C team looks forward to introducing the Micro C to the OTA’s world-wide membership of orthopaedic trauma surgeons and medical professionals, who look to the organization as the authoritative source for the optimum treatment and prevention of musculoskeletal injury.

As part of its initiative to connect with medical Industry leaders, Micro C recently joined the Medical Device Manufacturers Association (MDMA), the national trade association based in Washington, DC, which provides educational and advocacy assistance to innovative and entrepreneurial medical technology companies like Micro C. Evan Ruff, CEO, is a member of its Cybersecurity Working Group, examining the challenges facing the security of medical devices and their IT systems. Ruff describes his keen interest in sharing his expertise as “helping identify the best practices and initiatives to mitigate cybersecurity risks associated with connected medical devices, while benefiting from improved outcomes and reduction of the overall cost of care.”

About Micro C™
Micro C™ is a groundbreaking medical imaging solution designed for surgeons and physicians treating disorders of the extremities that combines a compact, hand-held X-ray and digital still, video and infrared camera, image receptor, software, service and consumables. It is designed to deliver greater accuracy, clarity, safety, speed, and integration, replacing 60-year-old X-ray and fluoroscopy equipment that is bulky, expensive and less safe. The Co-Founders and inventors are Greg Kolovich MD/MPH, orthopedic surgeon and Chief Medical Officer and Evan Ruff, Chief Executive Officer.

Learn more about Micro C Imaging online at Facebook and Twitter

Murem Sharpe
Micro C Imaging
912-247-4255
email us here


Source: EIN Presswire

Parents: Do you know enough about your teen athlete's sports supplements?

Here are 13 dangerous supplement poisons parents and coaches should worry about

Teens… aren’t adequately warned about dangerous supplements and are putting something they don’t really understand into their bodies — and put their health, and even their lives, at serious risk.”

— Robert Tauler

LOS ANGELES, CALIFORNIA, USA, August 31, 2017 /EINPresswire.com/ — It’s the start of high school football season and there’s no better time for parents to educate themselves to the dangers of sports supplements teenage athletes might be using as shortcuts to quickly add muscle, boost stamina, and get them more playing time on the field.

The serious health dangers of anabolic steroids are well known. Yet parents who wouldn’t consider letting their child play without a helmet are unaware of the harmful and illegal chemicals hidden inside modern sports supplements pushed by unscrupulous salesmen online and in supplement stores.

“Teens, and their parents, coaches and other adults in their lives, aren’t adequately warned about dangerous supplements and are putting something they don’t really understand into their bodies — and put their health, and even their lives, at serious risk,” said Los Angeles Attorney Robert Tauler, whose firm, Tauler Smith LLP, has successfully put dozens of supplement sellers out of business after taking them to court for selling steroids and other illegal performance enhancement drugs.

The worst are illegal designer steroids called prohormones, intended to chemically mask steroids, and a class of unapproved research drugs known as SARMS. The harmful side-effects of steroids are well known: Liver, kidney and heart failure; liver cancer; high blood pressure; strokes; acne; breast growth in males; impotence and shrunken testes; rage, severe mood swings and paranoia. Steroids also signal teenage bodies to stop growing.

Teenage athletes are also at risk of sudden cardiac arrest by taking re-workout supplements containing powerful stimulants.

Here are some of the most prevalent — and dangerous — substances to look out for in your teen's sports supplements.

PROHORMONES

Designer drugs, prohormones are created in laboratories with the sole purpose of masking illegal steroids. Think of them as Russian nesting dolls, with target steroids hidden within other steroids. They were banned in 2014 by the U.S. Congress under the Designer Anabolic Steroid Control Act.

For example, 1-DHEA was developed specifically to evade federal controlled substances laws by chemically camouflaging the anabolic steroid, 1-Testosterone, inside another banned substance, 1-Androstenediol. A person’s liver first breaks the 1-DHEA down into 1-Androstenediol, which, when metabolized, releases a flood of 1-Testosterone into the bloodstream.

1-DHEA is considered more dangerous than pure 1-Testosterone, because the metabolizing process takes a much larger toll on the liver. Because users also tend to take more 1-DHEA, and for longer periods, in order to achieve the desired results, organ damage is often greatly amplified.

Watch out for: DHEA and 1-DHEA; DMZ (Dimethazine); Methasterone (also known as Superdrol, synthesized by 1950s cancer tumor researchers and never approved for use); Methylstenbolone (Methylsten); Trenovar (masks Trenbolone, a drug that helps cattle gain weight); Halodrol (or CDMA), created by a known steroid producer.

SARMS (Selective Androgen Receptor Modulators)

These synthetic steroids are medical research drugs not approved for human consumption. Some are undergoing clinical trial for possible use in cancer treatment; others were yanked from studies due to their high toxicity.

Watch out for: Ostarine (or Enobosarm) which is still undergoing the rigorous clinical trial process for potential use in fighting some breast cancers; Andarine, investigated for possible use in people with osteoporosis or with enlarged, non-cancerous prostates; LGD-3303 and Ligandrol, also investigated for osteoporosis; and Cardarine, which was being investigated for use in cardiovascular disease but stopped due to sudden and rapid development of cancer in the study animals’ internal organs.

AMPHETAMINE ISOMERS

Pre-workout supplements are popular among teen athletes trying to push themselves to superior performance in the gym or on the practice field, which translates into more playing time during games.

The health risks of amphetamine isomers – chemical kin of amphetamines — include high blood pressure, excessive heart rate (tachycardia), strokes and cardiac arrest. The danger multiplies in supplements that add caffeine and caffeine-like ingredients such as guarana and taurine, commonly seen in energy drinks. The presence of laboratory-made amphetamines is often cloaked on ingredient lists by botanical names, to mislead consumers to believe the stimulant comes from a natural herb or root.

One of the most popular ingredients, DMAA (dimethylamylamine) — often incorrectly referred to as Geranium extract or Pelargonium graveolens extract — was developed by Eli Lily and Co. in the 1940s as a nasal decongestant. The pharmaceutical company withdrew DMAA from the market in 1983. The substance has led to the deaths of athletes and soldiers. It is also banned by all major sports governing bodies. Usain Bolt in January was among those stripped of an Olympic gold medal when the International Olympic Committee disqualified Jamaica’s 2008 4×10 relay team after teammate Nesta Carter’s stored blood tested positive for DMAA.

Look out for: The Texas shrub Acacia rigidula, which in reality is a man-made stimulant known as B-methylphenylethylamine (BMPEA). It has never been tested for safety in human use, and the only “clinical” test on record involved 10 men studied on behalf of the Florida company that makes and supplies the chemical to dietary supplement companies.

Robert Tauler
Tauler-Smith LLP
(310) 590-3927
email us here


Source: EIN Presswire

Dentures in Reading Help Berks County Residents Reclaim Their Smiles

dentist in reading pa, berks county dentist

dentures in reading, berks county dentures

Dentures in Reading are now more affordable thanks to Affordable Dental Solutions

Full, partial, and implant-retained dentures in Reading are an affordable solution to missing teeth.

We negotiate deals with the nation’s top denture manufacturers to ensure that our patients get the best dental prices in Berks County.”

— Dr. Kerri Ann Swan

READING, PENNSYLVANIA, UNITED STATES, August 31, 2017 /EINPresswire.com/ — At the flagship location of Affordable Dental Solutions in Reading, those with missing teeth can find a seamless solution. Full, partial, and implant-retained dentures in Reading are high in quality and low in price.

Full dentures are $495/arch and partial dentures are $595/arch. For patients who wish to stabilize their dentures with implants, implant-retained dentures in Reading start at $2,999 when two implants are added to an existing denture.

“No one should suffer because they can’t afford dental care,” says Dr. Kerri Ann Swan, dentures professional in Reading. “We negotiate deals with the nation’s top denture manufacturers to ensure that our patients get the best dental prices in Berks County.”

ADS also offers dental implants in Reading for only $2,000.

To learn more about affordable dental implants and dentures in Reading, request an appointment with ADS: http://www.affordabledentalsolutions.com/request-appointment/.

About Affordable Dental Solutions: Based in Eastern Pennsylvania, Affordable Dental Solutions is a provider of full dentistry services. For nearly a decade, Affordable Dental Solutions has offered patients procedures such as dental implants, crowns, and dentures at rates much lower than area competitors by utilizing state-of-the-art equipment and by negotiating discounts with implant manufacturing companies. Learn more at http://www.affordabledentalsolutions.com/

Jamie Jaskolka
Affordable Dental Solutions
(484) 948-2900
email us here

Glenn Mooney’s Patient Implant Denture Testimonial for Affordable Dental Solutions


Source: EIN Presswire

Acne Medication Market 2017 Global Industry Key Players, Share, Trend, Segmentation and Forecast to 2022

Acne Medication Market –Market Demand, Growth, Opportunities, Analysis of Top Key Players and Forecast to 2022

PUNE, INDIA, August 31, 2017 /EINPresswire.com/ — Acne Medication Market 2017

Wiseguyreports.Com adds “Acne Medication Market –Market Demand, Growth, Opportunities, Analysis of Top Key Players and Forecast to 2022” To Its Research Database.

Report Details:

The report provides in depth study of “Acne Medication Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Acne Medication Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

Global Acne Medication market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer;

This report focuses on the top players in global market, like 
Allergan 
Galderma 
Stiefel 
Valeant 
Bayer HealthCare 
BioPharmX 
Celtaxsys 
Johnson & Johnson 
Innovative Sciences 
Paratek Pharmaceuticals 
Promius Pharma 
Teva 
Versapharm 

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/1053555-global-acne-medication-market-research-report-2017

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Acne Medication in these regions, from 2012 to 2022 (forecast), covering 
North America 
Europe 
China 
Japan 
Southeast Asia 
India 

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into 
Injection 
Oral 
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Acne Medication for each application, including 
Hospital 
Clinic

If you have any special requirements, please let us know and we will offer you the report as you want.

Complete Report Details@ https://www.wiseguyreports.com/reports/1053555-global-acne-medication-market-research-report-2017

Major Key Points in Table of Content:

Global Acne Medication Market Research Report 2017 
1 Acne Medication Market Overview 
1.1 Product Overview and Scope of Acne Medication 
1.2 Acne Medication Segment by Type (Product Category) 
1.2.1 Global Acne Medication Production and CAGR (%) Comparison by Type (Product Category)(2012-2022) 
1.2.2 Global Acne Medication Production Market Share by Type (Product Category) in 2016 
1.2.3 Injection 
1.2.4 Oral 
1.3 Global Acne Medication Segment by Application 
1.3.1 Acne Medication Consumption (Sales) Comparison by Application (2012-2022) 
1.3.2 Hospital 
1.3.3 Clinic 
1.4 Global Acne Medication Market by Region (2012-2022) 
1.4.1 Global Acne Medication Market Size (Value) and CAGR (%) Comparison by Region (2012-2022) 
1.4.2 North America Status and Prospect (2012-2022) 
1.4.3 Europe Status and Prospect (2012-2022) 
1.4.4 China Status and Prospect (2012-2022) 
1.4.5 Japan Status and Prospect (2012-2022) 
1.4.6 Southeast Asia Status and Prospect (2012-2022) 
1.4.7 India Status and Prospect (2012-2022) 
1.5 Global Market Size (Value) of Acne Medication (2012-2022) 
1.5.1 Global Acne Medication Revenue Status and Outlook (2012-2022) 
1.5.2 Global Acne Medication Capacity, Production Status and Outlook (2012-2022)

….

7 Global Acne Medication Manufacturers Profiles/Analysis 
7.1 Allergan 
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.1.2 Acne Medication Product Category, Application and Specification 
7.1.2.1 Product A 
7.1.2.2 Product B 
7.1.3 Allergan Acne Medication Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 
7.1.4 Main Business/Business Overview 
7.2 Galderma 
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.2.2 Acne Medication Product Category, Application and Specification 
7.2.2.1 Product A 
7.2.2.2 Product B 
7.2.3 Galderma Acne Medication Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 
7.2.4 Main Business/Business Overview 
7.3 Stiefel 
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.3.2 Acne Medication Product Category, Application and Specification 
7.3.2.1 Product A 
7.3.2.2 Product B 
7.3.3 Stiefel Acne Medication Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 
7.3.4 Main Business/Business Overview 
7.4 Valeant 
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.4.2 Acne Medication Product Category, Application and Specification 
7.4.2.1 Product A 
7.4.2.2 Product B 
7.4.3 Valeant Acne Medication Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 
7.4.4 Main Business/Business Overview 
7.5 Bayer HealthCare 
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.5.2 Acne Medication Product Category, Application and Specification 
7.5.2.1 Product A 
7.5.2.2 Product B 
7.5.3 Bayer HealthCare Acne Medication Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 
7.5.4 Main Business/Business Overview 
7.6 BioPharmX 
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.6.2 Acne Medication Product Category, Application and Specification 
7.6.2.1 Product A 
7.6.2.2 Product B 
7.6.3 BioPharmX Acne Medication Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 
7.6.4 Main Business/Business Overview 
7.7 Celtaxsys 
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.7.2 Acne Medication Product Category, Application and Specification 
7.7.2.1 Product A 
7.7.2.2 Product B 
7.7.3 Celtaxsys Acne Medication Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 
7.7.4 Main Business/Business Overview 
7.8 Johnson & Johnson 
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.8.2 Acne Medication Product Category, Application and Specification 
7.8.2.1 Product A 
7.8.2.2 Product B 
7.8.3 Johnson & Johnson Acne Medication Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 
7.8.4 Main Business/Business Overview 
7.9 Innovative Sciences 
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.9.2 Acne Medication Product Category, Application and Specification 
7.9.2.1 Product A 
7.9.2.2 Product B 
7.9.3 Innovative Sciences Acne Medication Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 
7.9.4 Main Business/Business Overview 
7.10 Paratek Pharmaceuticals 
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.10.2 Acne Medication Product Category, Application and Specification 
7.10.2.1 Product A 
7.10.2.2 Product B 
7.10.3 Paratek Pharmaceuticals Acne Medication Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 
7.10.4 Main Business/Business Overview 

Continued….

Buy now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=1053555

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Professional Diagnostics Market 2017 Global Share, Trend, Segmentation and Forecast to 2021

The analysts forecast the global professional diagnostics market to grow at a CAGR of 6.76% during the period 2016-2020.

PUNE, INDIA, August 31, 2017 /EINPresswire.com/ —

Global Professional Diagnostics Market

Description

WiseGuyReports.Com adds” Global Professional Diagnostics Market 2016-2020 “Research To Its Database.

The global professional diagnostics market is expected to grow at a high rate in the forecast period. Factors such as increasing aging population and rise in incidence and prevalence of chronic diseases and infections are driving the market. Cancer, tuberculosis, malaria, diabetes, and cardiovascular diseases are the main factors for the increasingly diagnosed population. In addition, increasing public awareness, rapid technological innovations, product approvals from regulatory authorities, and new product launches are expected to have a positive impact on the market over the next few years.

Covered in this report 
The report covers the present scenario and the growth prospects of the global professional diagnostics market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of in-vitro diagnostics (IVD) instruments.

 

Get sample Report @  https://www.wiseguyreports.com/sample-request/742793-global-professional-diagnostics-market-2016-2020

 

The market is divided into the following segments based on geography: 
• Americas 
• APAC 
• EMEA

The Global Professional Diagnostics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors 
• Abbott Diagnostics 
• Danaher 
• Roche Diagnostics 
• Siemens Healthcare 
• Thermo Fisher Scientific

Other prominent vendors 
• A&T Corporation 
• Menarini Diagnostics 
• Abaxis 
• Abcam 
• Accriva Diagnostics 
• Acon Laboratories 
• Affymetrix 
• Ahram Biosystem 
• ARKRAY 
• AsuraGen 
• Biocartis 
• Bio-Rad Laboratories 
• CellaVision 
• Cepheid 
• Chembio Diagnostic Systems 
• Clarity Diagnostics 
• Corgenix 
• DiagCor 
• Drucker Diagnostics 
• EKF Molecular Diagnostics 
• Erba Diagnostics 
• Green Cross Medis 
• Helena Laboratories 
• Hologic 
• HORIBA 
• Instrumentation Laboratory 
• i-Sens 
• Landwind Medical 
• Mindray 
• Nihon Kohden 
• Nipro Diagnostics 
• Randox Laboratories 
• Sekisui Medical 
• Sienco 
• Sinduri Biotec 
• Snibe Diagnostics 
• Stago 
• Trivitron Healthcare

Market driver 
• Growing focus on diagnosing life-threatening conditions boosts POCT segment. 
• For a full, detailed list, view our report

Market challenge 
• Industry consolidation posing threat to new entrants. 
• For a full, detailed list, view our report

Market trend 
• Renting and leasing of professional diagnostics instruments. 
• For a full, detailed list, view our report

Key questions answered in this report 
• What will the market size be in 2020 and what will the growth rate be? 
• What are the key market trends? 
• What is driving this market? 
• What are the challenges to market growth? 
• Who are the key vendors in this market space? 
• What are the market opportunities and threats faced by the key vendors? 
• What are the strengths and weaknesses of the key vendors?

Report Details @ https://www.wiseguyreports.com/reports/742793-global-professional-diagnostics-market-2016-2020

 

Table of Contents -Major Key Points

 

PART 01: Executive summary 

PART 02: Scope of the report 

PART 03: Market research methodology 
• Research methodology 
• Economic indicators 

PART 04: Introduction 
• Key market highlights 

PART 05: Market landscape 
• Market overview 
• Market size and forecast 
• Five forces analysis 

PART 06: Market segmentation by product 
• Immunochemistry 
• Clinical microbiology 
• POCT 
• Hematology 
• Hemostasis 

PART 07: Market segmentation by end-user 

PART 08: Geographical segmentation 
• Professional diagnostics market in Americas 
• Professional diagnostics market in EMEA 
• Professional diagnostics market in APAC 

PART 09: Market drivers 
• Increasing industrial partnerships driving the growth of the market 
• Growing focus on diagnosing life-threatening conditions boosts POCT segment 
• Potential opportunities for physician office laboratories (POL) 

PART 10: Impact of drivers 

PART 11: Market challenges 
• Professional challenges in clinical microbiology and infectious diseases in Europe 
• Strained laboratory budgets and lowering reimbursement effecting instrument sales 
• Industry consolidation posing threat to new entrants 
• Limitations of closed systems in professional diagnostics testing 

PART 12: Impact of drivers and challenges 

PART 13: Market trends 
• Launch of novel tests in lung and colon cancer influencing the market growth of PD devices 
• Renting and leasing of professional diagnostics instruments 
• Multiple technologies-based hematology analyzers 
• Paradigm shift toward focused investments by vendors is increasing the market competition 

PART 14: Vendor landscape 
• Competitive scenario 

PART 15: Key vendor analysis 
• Abbott Diagnostics 
• Danaher Corporation 
• Roche Diagnostics 
• Siemens Healthcare 
• Thermo Fisher Scientific 
• Analysis of other tier-1 companies 
• Other prominent vendors 

………..CONTINUED

 

Buy Now@ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=742793

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Global Air Ambulance Services Market 2017 Share, Trend, Segmentation and Forecast to 2022

Air Ambulance Services Market –Market Demand, Growth, Opportunities, Analysis of Top Key Players and Forecast to 2022

PUNE, INDIA, August 31, 2017 /EINPresswire.com/ — Air Ambulance Services Market 2017

Wiseguyreports.Com adds “Air Ambulance Services Market –Market Demand, Growth, Opportunities, Analysis of Top Key Players and Forecast to 2022” To Its Research Database.

Report Details:

The report provides in depth study of “Air Ambulance Services Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Air Ambulance Services Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

This report studies the global Air Ambulance Services market, analyzes and researches the Air Ambulance Services development status and forecast in United States, EU, Japan, China, India and Southeast Asia.

This report focuses on the top players in global market, like 
AMR 
PHI Air Medical 
Scandinavian Air Ambulance 
Express AirMed Transport 
IAS Medical 
Lifeguard Air Ambulance 
Native American Air Ambulance 
REVA Air Ambulance 
Acadian

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/1067522-global-air-ambulance-services-market-size-status-and-forecast-2022

Market segment by Regions/Countries, this report covers 
United States 
EU 
Japan 
China 
India 
Southeast Asia

Market segment by Type, Air Ambulance Services can be split into 
Rotary-Wing 
Fixed-Wing

Market segment by Application, Air Ambulance Services can be split into 
Domestic Air Medical Rescue 
International Air Medical Rescue

If you have any special requirements, please let us know and we will offer you the report as you want.

Complete Report Details@ https://www.wiseguyreports.com/reports/1067522-global-air-ambulance-services-market-size-status-and-forecast-2022

Major Key Points in Table of Content:

Global Air Ambulance Services Market Size, Status and Forecast 2022 
1 Industry Overview of Air Ambulance Services 
1.1 Air Ambulance Services Market Overview 
1.1.1 Air Ambulance Services Product Scope 
1.1.2 Market Status and Outlook 
1.2 Global Air Ambulance Services Market Size and Analysis by Regions 
1.2.1 United States 
1.2.2 EU 
1.2.3 Japan 
1.2.4 China 
1.2.5 India 
1.2.6 Southeast Asia 
1.3 Air Ambulance Services Market by Type 
1.3.1 Rotary-Wing 
1.3.2 Fixed-Wing 
1.4 Air Ambulance Services Market by End Users/Application 
1.4.1 Domestic Air Medical Rescue 
1.4.2 International Air Medical Rescue

2 Global Air Ambulance Services Competition Analysis by Players 
2.1 Air Ambulance Services Market Size (Value) by Players (2016 and 2017) 
2.2 Competitive Status and Trend 
2.2.1 Market Concentration Rate 
2.2.2 Product/Service Differences 
2.2.3 New Entrants 
2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles 
3.1 AMR 
3.1.1 Company Profile 
3.1.2 Main Business/Business Overview 
3.1.3 Products, Services and Solutions 
3.1.4 Air Ambulance Services Revenue (Value) (2012-2017) 
3.1.5 Recent Developments 
3.2 PHI Air Medical 
3.2.1 Company Profile 
3.2.2 Main Business/Business Overview 
3.2.3 Products, Services and Solutions 
3.2.4 Air Ambulance Services Revenue (Value) (2012-2017) 
3.2.5 Recent Developments 
3.3 Scandinavian Air Ambulance 
3.3.1 Company Profile 
3.3.2 Main Business/Business Overview 
3.3.3 Products, Services and Solutions 
3.3.4 Air Ambulance Services Revenue (Value) (2012-2017) 
3.3.5 Recent Developments 
3.4 Express AirMed Transport 
3.4.1 Company Profile 
3.4.2 Main Business/Business Overview 
3.4.3 Products, Services and Solutions 
3.4.4 Air Ambulance Services Revenue (Value) (2012-2017) 
3.4.5 Recent Developments 
3.5 IAS Medical 
3.5.1 Company Profile 
3.5.2 Main Business/Business Overview 
3.5.3 Products, Services and Solutions 
3.5.4 Air Ambulance Services Revenue (Value) (2012-2017) 
3.5.5 Recent Developments 
3.6 Lifeguard Air Ambulance 
3.6.1 Company Profile 
3.6.2 Main Business/Business Overview 
3.6.3 Products, Services and Solutions 
3.6.4 Air Ambulance Services Revenue (Value) (2012-2017) 
3.6.5 Recent Developments 
3.7 Native American Air Ambulance 
3.7.1 Company Profile 
3.7.2 Main Business/Business Overview 
3.7.3 Products, Services and Solutions 
3.7.4 Air Ambulance Services Revenue (Value) (2012-2017) 
3.7.5 Recent Developments 
3.8 REVA Air Ambulance 
3.8.1 Company Profile 
3.8.2 Main Business/Business Overview 
3.8.3 Products, Services and Solutions 
3.8.4 Air Ambulance Services Revenue (Value) (2012-2017) 
3.8.5 Recent Developments 
3.9 Acadian 
3.9.1 Company Profile 
3.9.2 Main Business/Business Overview 
3.9.3 Products, Services and Solutions 
3.9.4 Air Ambulance Services Revenue (Value) (2012-2017) 
3.9.5 Recent Developments

Continued….

Buy now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=1067522

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Consumer Healthcare Products Market 2017 – Production, Sales, Supply, Demand, Analysis & Forecast to 2022

This report covers market characteristics, size and growth, segmentation, regional breakdowns, competitive landscape, market shares, trends and strategies

PUNE, INDIA, August 31, 2017 /EINPresswire.com/ — In this report, the global Consumer Healthcare Products market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Consumer Healthcare Products in these regions, from 2012 to 2022 (forecast), covering
North America
Europe
China
Japan
Southeast Asia
India

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/1991161-global-consumer-healthcare-products-market-research-report-2017

Global Consumer Healthcare Products market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Pfizer, Inc.
Bayer AG
Abbott Laboratories
GlaxosmithKline plc
Sanofi
GSK
Mylan
Johnson & Johnson
Merck
Ipsen, Sanofi S.A.
Piramal Enterprises Ltd.
Sun Pharmaceuticals Ltd.
Glenmark Pharmaceuticals Ltd.
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Pain Relief Product
Oral Health Product
Respiratory Product
Nutrition/Gastro Intestinal Product
Skin Health Product
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Consumer Healthcare Products for each application, including
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

Access Complete Report @ https://www.wiseguyreports.com/reports/1991161-global-consumer-healthcare-products-market-research-report-2017

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

Global Consumer Healthcare Products Market Research Report 2017
1 Consumer Healthcare Products Market Overview
1.1 Product Overview and Scope of Consumer Healthcare Products
1.2 Consumer Healthcare Products Segment by Type (Product Category)
1.2.1 Global Consumer Healthcare Products Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
1.2.2 Global Consumer Healthcare Products Production Market Share by Type (Product Category) in 2016
1.2.3 Pain Relief Product
1.2.4 Oral Health Product
1.2.5 Respiratory Product
1.2.6 Nutrition/Gastro Intestinal Product
1.2.7 Skin Health Product
1.3 Global Consumer Healthcare Products Segment by Application
1.3.1 Consumer Healthcare Products Consumption (Sales) Comparison by Application (2012-2022)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Global Consumer Healthcare Products Market by Region (2012-2022)
1.4.1 Global Consumer Healthcare Products Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
1.4.2 North America Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 China Status and Prospect (2012-2022)
1.4.5 Japan Status and Prospect (2012-2022)
1.4.6 Southeast Asia Status and Prospect (2012-2022)
1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Consumer Healthcare Products (2012-2022)
1.5.1 Global Consumer Healthcare Products Revenue Status and Outlook (2012-2022)
1.5.2 Global Consumer Healthcare Products Capacity, Production Status and Outlook (2012-2022)

2 Global Consumer Healthcare Products Market Competition by Manufacturers
2.1 Global Consumer Healthcare Products Capacity, Production and Share by Manufacturers (2012-2017)
2.1.1 Global Consumer Healthcare Products Capacity and Share by Manufacturers (2012-2017)
2.1.2 Global Consumer Healthcare Products Production and Share by Manufacturers (2012-2017)
2.2 Global Consumer Healthcare Products Revenue and Share by Manufacturers (2012-2017)
2.3 Global Consumer Healthcare Products Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Consumer Healthcare Products Manufacturing Base Distribution, Sales Area and Product Type
2.5 Consumer Healthcare Products Market Competitive Situation and Trends
2.5.1 Consumer Healthcare Products Market Concentration Rate
2.5.2 Consumer Healthcare Products Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Consumer Healthcare Products Capacity, Production, Revenue (Value) by Region (2012-2017)
3.1 Global Consumer Healthcare Products Capacity and Market Share by Region (2012-2017)
3.2 Global Consumer Healthcare Products Production and Market Share by Region (2012-2017)
3.3 Global Consumer Healthcare Products Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global Consumer Healthcare Products Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America Consumer Healthcare Products Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe Consumer Healthcare Products Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China Consumer Healthcare Products Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan Consumer Healthcare Products Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia Consumer Healthcare Products Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India Consumer Healthcare Products Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Consumer Healthcare Products Supply (Production), Consumption, Export, Import by Region (2012-2017)
4.1 Global Consumer Healthcare Products Consumption by Region (2012-2017)
4.2 North America Consumer Healthcare Products Production, Consumption, Export, Import (2012-2017)
4.3 Europe Consumer Healthcare Products Production, Consumption, Export, Import (2012-2017)
4.4 China Consumer Healthcare Products Production, Consumption, Export, Import (2012-2017)
4.5 Japan Consumer Healthcare Products Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Consumer Healthcare Products Production, Consumption, Export, Import (2012-2017)
4.7 India Consumer Healthcare Products Production, Consumption, Export, Import (2012-2017)

5 Global Consumer Healthcare Products Production, Revenue (Value), Price Trend by Type
5.1 Global Consumer Healthcare Products Production and Market Share by Type (2012-2017)
5.2 Global Consumer Healthcare Products Revenue and Market Share by Type (2012-2017)
5.3 Global Consumer Healthcare Products Price by Type (2012-2017)
5.4 Global Consumer Healthcare Products Production Growth by Type (2012-2017)

……Continued

Purchase Report @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=1991161

Norah Trent
Wise Guy Consultants Pvt. Ltd.
+1 (339) 368 6938 (US)/+91 841 198 5042 (IND)
email us here


Source: EIN Presswire

Arizona Mesothelioma Victims Center Now Offers a Auto Brake Technician with Mesothelioma in Arizona Instant Access to the Nation's Top Compensation Lawyers for a Better Outcome

Write down a list of co-workers who witnessed your exposure to asbestos. Again, this is vital information ”

— Arizona Mesothelioma Victims Center

NEW YORK, NEW YORK, USA, August 31, 2017 /EINPresswire.com/ — The Arizona Mesothelioma Victims Center is urging an auto mechanic or auto brake repairman who has just been diagnosed with mesothelioma in Arizona to take their possible financial compensation very seriously. The group wants a person like this to know that if this rare cancer has been diagnosed, there are extremely skilled attorneys who have been personally getting the best mesothelioma compensation results for individuals like a mechanic for over a decade.

As the group would like to explain anytime at 800-714-0303 the fulltime mesothelioma attorneys they suggest also make house calls and their experience and skill is obvious once they talk to the person with this rare cancer. http://Arizona.MesotheliomaVictimsCenter.Com

In the early 1980s, US car and truck manufacturers were required to stop installing asbestos lined brake pads or brake linings as it was well known as a hazard to the health of workers. The unfortunate reality is that mechanics or brake technicians were still being exposed to asbestos on auto/truck brakes on a very regular basis until the mid-1990s as the engineering of asbestos components on new vehicles stopped, but the maintenance and repair of them did not.

Auto/truck mechanics or brake technicians in Arizona who have recently been diagnosed with mesothelioma are urged to call the Arizona Mesothelioma Victims Center anytime at 800-714-0303 for a very honest conversation about mesothelioma compensation as well as specific attorneys they should be talking to. http://Arizona.MesotheliomaVictimsCenter.Com

The Arizona Mesothelioma Victims Center says, "If we had two vital tips for an auto/truck mechanic or auto/truck brake technician in Arizona who has been recently been diagnosed with mesothelioma it would be: "List the specific brake or auto parts that contained asbestos that you worked with on a regular basis. This is incredibly vital information for extremely skilled mesothelioma attorneys because it is this specific information that becomes the basis for the mesothelioma compensation claim. Write down a list of co-workers who witnessed your exposure to asbestos. Again, this is vital information when it comes to a mesothelioma compensation claim as we would like to explain anytime at 800-714-0303." http://Arizona.MesotheliomaVictimsCenter.Com

For more information about asbestos or asbestos in the workplace please review the EPA's website on this topic: https://www.epa.gov/asbestos.

For the best possible mesothelioma treatment options in Arizona the Arizona Mesothelioma Victims Center strongly recommends the following heath care facilities with the offer to help a diagnosed victim, or their family get to the right physicians at each hospital.

The Mayo Clinic Phoenix/Scottsdale, Arizona: http://www.mayoclinic.org/departments-centers/mayo-clinic-cancer-center.
The University of Arizona Medical Center Tucson, Arizona:
http://azcc.arizona.edu/profile/linda-garland
The Arizona Mesothelioma Victims Center would like to emphasize theirs is a statewide initiative available to a diagnosed victim anywhere in Arizona including communities such as Phoenix, Tucson, Mesa, Chandler, Glendale, Gilbert, Tempe. Peoria, or Prescott. http://Arizona.MesotheliomaVictimsCenter.Com

High-risk work groups for exposure to asbestos in Arizona include US Navy Veterans, power plant workers, manufacturing workers, plumbers, nuclear power plant workers, electricians, auto mechanics, machinists, or construction workers. Typically, these high-risk workers were exposed to asbestos in the 1950’s, 1960’s, 1970’s, or 1980’s.

The states indicated with the highest incidence of mesothelioma include Maine, Massachusetts, Connecticut, Maryland, New Jersey, Pennsylvania, Ohio, West Virginia, Virginia, Michigan, Illinois, Minnesota, Louisiana, Washington, and Oregon. Mesothelioma also happens in Arizona. http://Arizona.MesotheliomaVictimsCenter.com

For more information about mesothelioma please refer to the National Institutes of Health’s web site related to this rare form of cancer: http://www.nlm.nih.gov/medlineplus/mesothelioma.html

Michael Thomas
Arizona Mesothelioma Victims Center
800-714-0303
email us here


Source: EIN Presswire

Global Patient Registry Software Market 2017 Share, Trend, Segmentation and Forecast to 2022

Patient Registry Software Market –Market Demand, Growth, Opportunities, Analysis of Top Key Players and Forecast to 2022

PUNE, INDIA, August 31, 2017 /EINPresswire.com/ — Patient Registry Software Market 2017

Wiseguyreports.Com adds “Patient Registry Software Market –Market Demand, Growth, Opportunities, Analysis of Top Key Players and Forecast to 2022” To Its Research Database.

Report Details:

The report provides in depth study of “Patient Registry Software Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Patient Registry Software Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

This report studies the global Patient Registry Software market, analyzes and researches the Patient Registry Software development status and forecast in United States, EU, Japan, China, India and Southeast Asia.

This report focuses on the top players in global market, like 
Phytel, Inc 
Imagetrend, Inc 
FIGmd, Inc. 
Liaison Technologies 
CECity.com, Inc 
Dacima Software, Inc. 
Global Vision Technologies, Inc. (GVT) 
ifa systems AG 
INC RESEARCH HOLDINGS, INC. 
M2S, Inc. (A Medstreaming Company) 
McKesson Corporation 
QUINTILES IMS HOLDINGS, INC. 
Optum, Inc. (A Part of Unitedhealth Group, Inc.) 
EVADO Pty. Ltd. 
Velos, Inc.

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/1941963-global-patient-registry-software-market-size-status-and-forecast-2022

Market segment by Regions/Countries, this report covers 
United States 
EU 
Japan 
China 
India 
Southeast Asia

Market segment by Type, Patient Registry Software can be split into 
by Software 
by Delivery

Market segment by Application, Patient Registry Software can be split into 
Government Organizations & Third-Party Administrators (TPAs) 
Hospitals and Medical Practices 
Private Payers 
Pharmaceutical, Biotechnology, and Medical Device Companies 
Research Centers

If you have any special requirements, please let us know and we will offer you the report as you want.

Complete Report Details@ https://www.wiseguyreports.com/reports/1941963-global-patient-registry-software-market-size-status-and-forecast-2022

Major Key Points in Table of Content:

Global Patient Registry Software Market Size, Status and Forecast 2022 
1 Industry Overview of Patient Registry Software 
1.1 Patient Registry Software Market Overview 
1.1.1 Patient Registry Software Product Scope 
1.1.2 Market Status and Outlook 
1.2 Global Patient Registry Software Market Size and Analysis by Regions 
1.2.1 United States 
1.2.2 EU 
1.2.3 Japan 
1.2.4 China 
1.2.5 India 
1.2.6 Southeast Asia 
1.3 Patient Registry Software Market by Type 
1.3.1 by Software 
1.3.2 by Delivery 
1.4 Patient Registry Software Market by End Users/Application 
1.4.1 Government Organizations & Third-Party Administrators (TPAs) 
1.4.2 Hospitals and Medical Practices 
1.4.3 Private Payers 
1.4.4 Pharmaceutical, Biotechnology, and Medical Device Companies 
1.4.5 Research Centers

2 Global Patient Registry Software Competition Analysis by Players 
2.1 Patient Registry Software Market Size (Value) by Players (2016 and 2017) 
2.2 Competitive Status and Trend 
2.2.1 Market Concentration Rate 
2.2.2 Product/Service Differences 
2.2.3 New Entrants 
2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles 
3.1 Phytel, Inc 
3.1.1 Company Profile 
3.1.2 Main Business/Business Overview 
3.1.3 Products, Services and Solutions 
3.1.4 Patient Registry Software Revenue (Value) (2012-2017) 
3.1.5 Recent Developments 
3.2 Imagetrend, Inc 
3.2.1 Company Profile 
3.2.2 Main Business/Business Overview 
3.2.3 Products, Services and Solutions 
3.2.4 Patient Registry Software Revenue (Value) (2012-2017) 
3.2.5 Recent Developments 
3.3 FIGmd, Inc. 
3.3.1 Company Profile 
3.3.2 Main Business/Business Overview 
3.3.3 Products, Services and Solutions 
3.3.4 Patient Registry Software Revenue (Value) (2012-2017) 
3.3.5 Recent Developments 
3.4 Liaison Technologies 
3.4.1 Company Profile 
3.4.2 Main Business/Business Overview 
3.4.3 Products, Services and Solutions 
3.4.4 Patient Registry Software Revenue (Value) (2012-2017) 
3.4.5 Recent Developments 
3.5 CECity.com, Inc 
3.5.1 Company Profile 
3.5.2 Main Business/Business Overview 
3.5.3 Products, Services and Solutions 
3.5.4 Patient Registry Software Revenue (Value) (2012-2017) 
3.5.5 Recent Developments 
3.6 Dacima Software, Inc. 
3.6.1 Company Profile 
3.6.2 Main Business/Business Overview 
3.6.3 Products, Services and Solutions 
3.6.4 Patient Registry Software Revenue (Value) (2012-2017) 
3.6.5 Recent Developments 
3.7 Global Vision Technologies, Inc. (GVT) 
3.7.1 Company Profile 
3.7.2 Main Business/Business Overview 
3.7.3 Products, Services and Solutions 
3.7.4 Patient Registry Software Revenue (Value) (2012-2017) 
3.7.5 Recent Developments 
3.8 ifa systems AG 
3.8.1 Company Profile 
3.8.2 Main Business/Business Overview 
3.8.3 Products, Services and Solutions 
3.8.4 Patient Registry Software Revenue (Value) (2012-2017) 
3.8.5 Recent Developments 
3.9 INC RESEARCH HOLDINGS, INC. 
3.9.1 Company Profile 
3.9.2 Main Business/Business Overview 
3.9.3 Products, Services and Solutions 
3.9.4 Patient Registry Software Revenue (Value) (2012-2017) 
3.9.5 Recent Developments 
3.10 M2S, Inc. (A Medstreaming Company) 
3.10.1 Company Profile 
3.10.2 Main Business/Business Overview 
3.10.3 Products, Services and Solutions 
3.10.4 Patient Registry Software Revenue (Value) (2012-2017) 
3.10.5 Recent Developments 

Continued….

Buy now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=1941963

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Bakery & Cereals in Australia Market Analysis 2017 (By Segment, Key Players and Applications) and Forecasts To 2021

Bakery & Cereals in Australia Market Research Report 2017 Analysis and Forecast to 2021

PUNE, INDIA, August 31, 2017 /EINPresswire.com/ — Pune, India, 31st August 2017: WiseGuyReports announced addition of new report, titled “Top Growth Opportunities: Bakery & Cereals in Australia”.

Summary
Consumer and Market Insights "Top Growth Opportunities: Bakery & Cereals in Australia", provides an overview of the bakery and cereal market, analyzing market data, demographic consumption patterns within the category, and the key consumer trends driving consumption. The report highlights top growth opportunities for bakery & cereals market in Australia and outlines new product development that effectively targets the most pertinent consumer need states, and offers strategic recommendations to capitalize on evolving consumer landscapes.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/2030160-top-growth-opportunities-bakery-cereals-in-australia

This report identifies the key demographic groups driving consumption, and what motivates their consumption. When combined with an in-depth study of market and category dynamics, readers are able to identify key opportunities, and what they need to do in order to target them. The report uses a unique method of quantifying consumer trends to highlight the degree of influence they have on consumption within the category. The report also identifies the most important trends within the market and shows whether beliefs over what influences consumer behavior within the category are accurate.

This report brings together consumer analysis and market data to provide actionable insight into the behavior of Australia's Bakery & Cereals consumers. This is based on unique consumer data, developed from extensive consumption surveys and consumer group tracking, which quantifies the influence of 20 consumption motivations in the Bakery & Cereals sector. Category, brand, and packaging dynamics are also examined. This allows product and marketing strategies to be better aligned with the leading trends in the market.

Scope
– The Australian Bakery & Cereals market saw a small decline in US$ between 2011 and 2016, due to the depreciation of the Australian Dollar. However, the growth is forecast to change to positive in the next five years between 2016 and 2021.
– Australia ranks among the biggest markets in the global Bakery & Cereals sector in terms of per capita consumption, concretely third in 2016, and expected to become the second largest by 2021
– Opportunities for premiumization in Bakery & Cereals have been limited over the past five years, but this situation is expected to improve between 2016 and 2021.
– Domestic Bakery & Cereals brands in Australia have outperformed international ones.

Reasons to buy
Get access to –
– Key consumer demographic groups driving consumption within the Australian market. The figures showcase the number of times consumers of specific ages and gender consume Bakery & Cereals, as well as identifying whether these demographic groups "over" consume in the category (i.e. they account for a higher proportion of occasions than the proportion of society they represent overall)
– A study of market value and volumes over 2011-2016 for Australia, supplemented with category, brand and packaging analysis that shows the current state of the market, and how it will evolve over the 2016-2021 period
– The degree of influence that the 20 key consumer trends identified by GlobalData have on Bakery & Cereals consumption volumes, with granular analysis on the extent that degree of influences varies between gender and age group
– Insight into the implications behind the data, and analysis of how the consumer needs will evolve in the short-to-medium term future
– Examples of international and Australia-specific product innovation targeting key consumer needs

Table of Content: Key Points

1. Introducing a top growth market for Bakery & Cereals
Top 10 global growth opportunities scores
Top global issues
Assessment against global strategic issues
Predicted future issues for the global sector
Reward and risk assessment
Opportunity score – overview
Consumer spending trends – peer group comparisons
Political, Economic, Social, and Technological: Analysis
Enablers and inhibitors of growth
Rewards and opportunities for growth
Summary of the market

2. Market insight – identifying the opportunities to move into
Market growth by category
Value growth of the market
Volume growth of the market
Level of premiumization by category
Category analysis – key factors driving change

3. Retail and distribution insight – key channels and retailers driving growth
Bakery & Cereals retail channel share
Key Retail Channel trends
Routes to market
Drivers of change in the sector

4. Company and brand insight – the competitive landscape defined
Category fragmentation
Company and brand strength
…Continued

ACCESS REPORT @ https://www.wiseguyreports.com/reports/2030160-top-growth-opportunities-bakery-cereals-in-australia

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire